| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 05/05/2011 | CA2778895A1 Compositions and methods for treating inflammatory disorders |
| 05/05/2011 | CA2778526A1 Method for producing therapeutic proteins in pichia pastoris lacking dipeptidyl aminopeptidase activity |
| 05/05/2011 | CA2777487A1 Methods for the production of recombinant proteins with improved secretion efficiencies |
| 05/05/2011 | CA2776990A1 Sorf constructs and multiple gene expression |
| 05/04/2011 | EP2316963A1 Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
| 05/04/2011 | EP2316951A1 Binding domain-immunoglobulin fusion proteins |
| 05/04/2011 | EP2316950A1 Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same |
| 05/04/2011 | EP2316944A2 Binding agents: chimeric ligand/receptor proteins |
| 05/04/2011 | EP2316940A1 Focused libraries of genetic packages |
| 05/04/2011 | EP2316939A2 Novel peptide |
| 05/04/2011 | EP2316936A1 Method for analysis/identification of antibody gene at one-cell level |
| 05/04/2011 | EP2316922A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316921A1 Neutralizing human anti-IGFR antibody |
| 05/04/2011 | EP2316855A1 Antihuman Alpha-9 integrin antibody and use of the same |
| 05/04/2011 | EP2316851A1 Antibody inhibitors of GDF-8 and uses thereof |
| 05/04/2011 | EP2316843A1 Isolation of five novel genes coding for new Fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
| 05/04/2011 | EP2316486A2 Cripto blocking antibodies and uses thereof |
| 05/04/2011 | EP2316479A2 Pharmaceutical compositions comprising immunologically active herpes simplex virus (HSV) protein fragments |
| 05/04/2011 | EP1530643B1 Chimeric protein |
| 05/04/2011 | EP1456228B1 Method of isolation and purification of trypsin from pronase and use thereof |
| 05/04/2011 | EP1383532B1 Combination therapy |
| 05/04/2011 | EP1294746B1 Peptide conjugates modified n- and/or c-terminally by short charged peptide chains |
| 05/04/2011 | CN1500147B Improved gene expression |
| 05/04/2011 | CN102046803A Monoclonal antibodies to basic fibroblast growth factor |
| 05/04/2011 | CN102046802A Thermophilic and thermoacidophilic glycosylation genes and enzymes from alicyclobacillus acidocaldarius and related organisms, methods |
| 05/04/2011 | CN102046655A BCR-complex-specific antibodies and methods of using same |
| 05/04/2011 | CN102046652A Highly bridged peptides from Actinomadura namibiensis |
| 05/04/2011 | CN102046195A HER2/neu-specific antibodies and methods of using same |
| 05/04/2011 | CN102041266A Construction of carriers for prokaryotic expression and eukaryotic expression of candidate gene of porcine rota virus vaccines |
| 05/04/2011 | CN102041264A Genetic engineering bacterium of Gluconobacter oxydans (G.oxydans) and application thereof |
| 05/04/2011 | CN102041246A Human embryo retina transformed cell line for producing biological products |
| 05/04/2011 | CN102041238A Lactobacillus plantarum, method for fermenting and preparing bacteriocin of Lactobacillus plantarum, and application of Lactobacillus plantarum and bacteriocin |
| 05/04/2011 | CN102040662A Antibodies against human IL-21 receptor and uses therefor |
| 05/04/2011 | CN102040660A Recombinant protein as BNP (Brain Natriuretic Peptide) immunodiagnostic reagent standard as well as preparation method and application thereof |
| 05/04/2011 | CN102040657A Sequence optimization and efficient expression of bilin-binding protein (BBP) |
| 05/04/2011 | CN101555484B Recombinant human HMBOX1 expression vector, expression product thereof and antibody and application thereof |
| 05/04/2011 | CN101524370B Production technology of pig brain protolysate |
| 05/04/2011 | CN101492656B Glutamine-auxothrophic human cells capable of producing proteins and capable of growing in a glutamine-free medium |
| 05/04/2011 | CN101319244B Method of preparing glutathione freeze-dried powder |
| 05/04/2011 | CN101018854B Novel strains belonging to the genus paenibacillus and method of controlling plant disease by using these strains or culture thereof |
| 05/03/2011 | USRE42324 Compound for treatment of allergy and asthma |
| 05/03/2011 | US7935803 Polynucleotides encoding proteins for covalent tethering to functional groups and substrates |
| 05/03/2011 | US7935802 Lignan glycosidase and utilization of the same |
| 05/03/2011 | US7935797 Contacting with monoclonal antibody which binds to chemokine receptor; blocks fusion and inhibits activation of inflammatory response |
| 05/03/2011 | US7935795 Human monoclonal antibody binding to hGM-CSF and its antigen binding portion |
| 05/03/2011 | US7935794 MAdCAM antibodies |
| 05/03/2011 | US7935786 Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis |
| 05/03/2011 | US7935671 Pantropic neurotrophic factors |
| 05/03/2011 | US7935513 Combinatorial DNA library for producing modified N-glycans in lower eukaryotes |
| 05/03/2011 | US7935510 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms |
| 05/03/2011 | US7935509 Intracellular production of a nuclease |
| 05/03/2011 | US7935506 Method for producing a lower alkyl ester of α-L-aspartyl-L-phenylalanine |
| 05/03/2011 | US7935503 Methods for producing and using polymyxins |
| 05/03/2011 | US7935502 Hepatocyte growth factor (HGF) binding proteins |
| 05/03/2011 | US7935495 Methods of detecting early renal disease in animals |
| 05/03/2011 | US7935490 Immunodiagnostic assays using reducing agents |
| 05/03/2011 | US7935340 Antibodies to IL-6 and use thereof |
| 05/03/2011 | US7935336 Highly functional enzyme having α-galactosidase activity |
| 05/03/2011 | CA2469815C Methods for purifying protein |
| 05/03/2011 | CA2454048C Therapeutic agents comprising pro-apoptotic proteins |
| 05/03/2011 | CA2347066C Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof |
| 05/03/2011 | CA2342966C Gene alteration in the gene for the gbeta3 subunit of the human g protein |
| 05/03/2011 | CA2328485C Humanized antibodies that recognize verotoxin ii and cell line producing same |
| 05/03/2011 | CA2221893C Antibody specific for staphylococcus aureus, and use thereof |
| 05/03/2011 | CA2206509C Novel hedgehog-derived polypeptides |
| 04/28/2011 | WO2011050262A2 Dual variable domain immunoglobulins and uses thereof |
| 04/28/2011 | WO2011050152A2 Site-specific modification of proteins |
| 04/28/2011 | WO2011049836A1 Antibody heavy chain variable region (vh) domain exchange |
| 04/28/2011 | WO2011049418A2 Novel ginsenoside glycosidase derived from the genus terrabacter, and use thereof |
| 04/28/2011 | WO2011049157A1 Rapid display method in translational synthesis of peptide |
| 04/28/2011 | WO2011049082A1 INTEGRIN α8Β1-SPECIFIC MONOCLONAL ANTIBODY |
| 04/28/2011 | WO2009053852A3 Protein based foaming agents and methods of making thereof |
| 04/28/2011 | WO2008070943A3 Soluble dimerized or oligomerized endostatin |
| 04/28/2011 | US20110098450 Antibody Molecules |
| 04/28/2011 | US20110098443 Anti-GLP-1R Antibodies and Their Uses |
| 04/28/2011 | US20110098227 Soluble notch-based substrates for gamma secretase and methods and compositions for using same |
| 04/28/2011 | US20110098212 Cytokine |
| 04/28/2011 | US20110098211 Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same |
| 04/28/2011 | US20110098207 Cellulase-Free Enzyme Compositions and Host Cells for Producing the Same |
| 04/28/2011 | US20110098183 Plants with increased yield and/or increased tolerance to environmental stress (iy-bm) |
| 04/28/2011 | US20110097794 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
| 04/28/2011 | US20110097783 Proteases from gram-positive organisms |
| 04/28/2011 | US20110097760 Method For Producing a Casein Hydrolysate |
| 04/28/2011 | US20110097749 Process for producing hepcidin |
| 04/28/2011 | US20110097741 Partial t1r2 nucleic acid sequence, receptor protein and its use in screening assays |
| 04/28/2011 | US20110097737 Methods and Compositions for Targeting Proteins of Interest to the Host Cell Envelope |
| 04/28/2011 | US20110097733 Process for the production of a hybridoma and antibody obtained therefrom, able to recognize more than one vitamin d metabolite |
| 04/28/2011 | US20110097448 Protein Hydrolysate Compositions Stable Under Acidic Conditions |
| 04/28/2011 | US20110097444 Microbiological reprocessing of degumming residue formed during biodiesel production |
| 04/28/2011 | US20110097359 Production of diphtheria toxin |
| 04/28/2011 | US20110097358 RESPIRATORY SYNCYTIAL VIRUS (RSV) VIRUS-LIKE PARTICLES (VLPs) |
| 04/28/2011 | US20110097357 Bioconjugates made from recombinant n-glycosylated proteins from procaryotic cells |
| 04/28/2011 | US20110097355 Virus-like particles as vaccines for paramyxovirus |
| 04/28/2011 | US20110097342 Binding agents |
| 04/28/2011 | US20110097340 Fully human anti-vegf antibodies and methods of using |
| 04/28/2011 | US20110097339 Compositions monovalent for CD28 binding and methods of use |
| 04/28/2011 | US20110097336 Methods for modulating mannose content of recombinant proteins |
| 04/28/2011 | US20110097334 Novel Marker Genes for Regulatory T Cells from Human Blood |
| 04/28/2011 | US20110097314 Method for producing a composition for promoting survival of transplanted hematopoietic stem cell |
| 04/28/2011 | US20110097262 NOVEL ANTI-cMET ANTIBODY |